Intersect ENT | TalkMarkets

Article By: Jim Van Meerten

Monday, September 11, 2017 5:50 PM EDT

Since the Trend Spotter signaled a buy on 8/3 the stock gained 11.00%.

In this article: XENT

Article By: Joe Kunkle

Wednesday, June 8, 2016 7:04 AM EDT

In the final part of my series looking at Med-Tech M&A landscape I focus on a diverse group of names, and come to find XENT is the most compelling.

In this article: HAE, CYNO, CNMD, IART, WMGI, ZLTQ, XENT, ENTL, PEN, NVRO Also: LDRH, ZBH

Article By: Jim Van Meerten

Friday, February 27, 2015 9:01 PM EDT

XENT earnings are estimated to increase 39.80% this year and an additional 64.90% next year

In this article: XENT